martes, 1 de octubre de 2019

Novartis partners with Microsoft to use AI in drug development - STAT

Novartis partners with Microsoft to use AI in drug development - STAT

Cancer Briefing

STAT Plus: Novartis partners with Microsoft to use AI in drug development

By REBECCA ROBBINS


JOHANNES EISELE/AFP/GETTY IMAGES
Novartis and Microsoft will use artificial intelligence to design molecules, personalize medication dosing, and optimize the manufacture of cancer therapy.

No hay comentarios: